SMTL ID : 4jz0.1

X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with CTT1055

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.83 Å

Oligo State

homo-dimer

Ligands

6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain A: N.35, Q.54, S.57, Q.58 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:Q.54 Hydrogen bonds: A:S.57 NAG-NAG.2: 5 residues within 4Å: Chain A: Y.86, E.96, I.97, F.98, N.99 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 5 residues within 4Å: Chain A: S.431, L.432, N.435, P.553, Q.610 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.610 NAG-NAG.13: 4 residues within 4Å: Chain B: N.35, Q.54, S.57, Q.58 2 PLIP interactions: 2 interactions with chain B Hydrophobic interactions: B:Q.54 Hydrogen bonds: B:S.57 NAG-NAG.14: 5 residues within 4Å: Chain B: Y.86, E.96, I.97, F.98, N.99 No protein-ligand interaction detected (PLIP) NAG-NAG.15: 5 residues within 4Å: Chain B: S.431, L.432, N.435, P.553, Q.610 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:Q.610

2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)

NAG-NAG-BMA-MAN.4: 9 residues within 4Å: Chain A: S.590, S.593, A.594, N.597, Q.699 Chain B: H.71, E.235, Y.236, R.313 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:E.235, B:E.235, B:R.313, B:R.313 NAG-NAG-BMA-MAN.16: 9 residues within 4Å: Chain A: H.71, E.235, Y.236, R.313 Chain B: S.590, S.593, A.594, N.597, Q.699 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.235, A:E.235, A:R.313, A:R.313

4 x ZN: ZINC ION(Non-covalent)

ZN.5: 6 residues within 4Å: Chain A: D.346, E.384, Y.511, H.512 Ligands: ZN.6, T01.12 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:D.346, A:E.384, A:E.384, A:H.512 ZN.6: 7 residues within 4Å: Chain A: H.336, D.346, E.383, E.384, D.412 Ligands: ZN.5, T01.12 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.336, A:D.346, A:D.412, A:D.412 ZN.17: 6 residues within 4Å: Chain B: D.346, E.384, Y.511, H.512 Ligands: ZN.18, T01.24 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:D.346, B:E.384, B:E.384, B:H.512 ZN.18: 7 residues within 4Å: Chain B: H.336, D.346, E.383, E.384, D.412 Ligands: ZN.17, T01.24 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:H.336, B:D.346, B:D.412, B:D.412

2 x CA: CALCIUM ION(Non-covalent)

CA.7: 4 residues within 4Å: Chain A: T.228, Y.231, E.392, E.395 5 PLIP interactions: 5 interactions with chain A Metal complexes: A:T.228, A:Y.231, A:E.392, A:E.392, A:E.395 CA.19: 4 residues within 4Å: Chain B: T.228, Y.231, E.392, E.395 5 PLIP interactions: 5 interactions with chain B Metal complexes: B:T.228, B:Y.231, B:E.392, B:E.392, B:E.395

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.8: 4 residues within 4Å: Chain A: N.410, D.412, R.493, R.495 Ligand excluded by PLIP CL.20: 4 residues within 4Å: Chain B: N.410, D.412, R.493, R.495 Ligand excluded by PLIP

6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.9: 4 residues within 4Å: Chain A: N.80, T.82, H.83, T.308 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:T.308 Hydrogen bonds: A:T.82, A:H.83 NAG.10: 2 residues within 4Å: Chain A: N.154, S.156 No protein-ligand interaction detected (PLIP) NAG.11: 4 residues within 4Å: Chain A: W.205, N.418, F.524, Y.525 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:W.205, A:Y.525 Hydrogen bonds: A:W.205, A:F.524 Water bridges: A:N.418 NAG.21: 4 residues within 4Å: Chain B: N.80, T.82, H.83, T.308 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:T.308 Hydrogen bonds: B:T.82, B:H.83 NAG.22: 2 residues within 4Å: Chain B: N.154, S.156 No protein-ligand interaction detected (PLIP) NAG.23: 4 residues within 4Å: Chain B: W.205, N.418, F.524, Y.525 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:W.205, B:Y.525 Hydrogen bonds: B:W.205, B:F.524 Water bridges: B:N.418

2 x T01: N-(4-fluorobenzoyl)-L-gamma-glutamyl-O-[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]-L-serine(Non-covalent)

T01.12: 24 residues within 4Å: Chain A: K.166, F.168, R.169, Y.193, N.216, H.336, D.346, E.383, E.384, G.386, L.387, D.412, G.477, N.478, R.493, R.495, Y.511, H.512, N.657, K.658, Y.659, A.660 Ligands: ZN.5, ZN.6 23 PLIP interactions: 23 interactions with chain A Hydrophobic interactions: A:L.387, A:Y.511, A:Y.659, A:Y.659, A:Y.659 Hydrogen bonds: A:N.216, A:G.477, A:N.478, A:Y.511 Water bridges: A:G.165, A:R.169, A:Q.213, A:D.346, A:R.493, A:R.495, A:G.507, A:G.507, A:K.658 Salt bridges: A:R.169, A:R.493, A:R.495, A:H.512, A:K.658 T01.24: 24 residues within 4Å: Chain B: K.166, F.168, R.169, Y.193, N.216, H.336, D.346, E.383, E.384, G.386, L.387, D.412, G.477, N.478, R.493, R.495, Y.511, H.512, N.657, K.658, Y.659, A.660 Ligands: ZN.17, ZN.18 24 PLIP interactions: 24 interactions with chain B Hydrophobic interactions: B:L.387, B:Y.511, B:Y.659, B:Y.659, B:Y.659 Hydrogen bonds: B:N.216, B:D.346, B:G.477, B:N.478, B:Y.511 Water bridges: B:G.165, B:R.169, B:Q.213, B:D.346, B:R.493, B:R.495, B:G.507, B:G.507, B:K.658 Salt bridges: B:R.169, B:R.493, B:R.495, B:H.512, B:K.658

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ganguly, T. et al., A high affinity 18F-labeled phosphoramidate peptidomimetic inhibitor as a PSMA-targeted PET imaging agent for prostate cancer. To be Published

Release Date

2014-04-02

Peptides

Glutamate carboxypeptidase 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Glutamate carboxypeptidase 2

Related Entries With Identical Sequence